1 Communicating uncertainty - Illustrated by the new approach for risk assessment (Margin of Exposure) 1 TECHNICAL TRAINING ON RISK ANALYSIS FOR SAARC COUNTRIES FAO RAP, Bangkok, Thailand Quality Council of India Delhi, India, June 17-21, 2013 John LUM Scientific Officer Centre for Food Safety Hong Kong
34
Embed
Communicating uncertainty - Illustrated by the new …€¦ · · 2013-07-183 “All substances are poisons; there is none which is not a poison. The right dose differentiates a
This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
1
Communicating uncertainty - Illustrated by the new
approach for risk assessment (Margin of Exposure)
1
TECHNICAL TRAINING ON RISK ANALYSIS FOR
SAARC COUNTRIES
FAO RAP, Bangkok, Thailand Quality Council of India Delhi, India, June 17-21, 2013
John LUM Scientific Officer
Centre for Food Safety Hong Kong
2
Content
Dose Response Assessment
Health-based Guidance Values
Margin of Exposure (MOE)
Example of Risk Assessment using MOE –
Acrylamide
3
“All substances are poisons; there is none
which is not a poison. The right dose
differentiates a poison and a remedy”. Paracelsus, 1538
Aspirin taken for a headache:
- one lick of a pill won’t have desired effect
- two pills should relieve pain
- the entire packet could poison
Dose-response Assessment (1)
4
Dose-response Assessment (2)
The determination of the relationship between
magnitude of exposure (dose) to an agent
and the severity and/or frequency of the
adverse health effects (response)
By toxicological tests / experimental data
To derive health-based guidance values
5
A typical dose-response curve
0
20
40
60
80
100
Dose
Response
0.10.01 1 10 100 1000
NOAEL
6
NOAEL (No-observed-adverse-effect level)
Greatest concentration or amount of a substance, found
by experiment or observation, that causes no adverse
alteration of morphology, functional capacity, growth,
development or lifespan of the target organism
distinguishable from those observed in normal (control)
organisms of the same species and strain under the same
defined conditions of exposure
Dose-response Assessment (3)
7
Uncertainties of NOAEL
From animal to human
Interspecies difference
Difference among individuals in human
population
Genetics, genders, diseases status
Dose-response Assessment (4)
Adapted from Andrew G Renwick, Pest Manag Sci 58: 1073-1082
9
Acceptable Daily Intake (ADI) NOAEL
Estimate of the amount of a substance in food
and/or drinking water, expressed on a body
weight basis that can be ingested daily over a
lifetime WITHOUT appreciable health risk
Health-based Guidance Values (1)
10
Use of dose-response curve to derive ADI
0
20
40
60
80
100
Dose
Response
0.10.01 1 10 100 1000
ADI
Average human
Sensitive human
10 10
UF
NOAEL
Test species
Toxic effect
For animal
to average human
For average human
to sensitive human
11
In general, toxic effect is assumed to have a
threshold
A quantitative expression of exposure Deterministic values
Exposure of substances below the health-based
guidance value without appreciable health risk
Health-based Guidance Values (2)
12
Additives, pesticide/veterinary drug residues
Intentionally added
Acceptable Daily Intake (ADI)
Contaminants
Tolerable Intakes
Permissible levels of intake of contaminants
unavoidably associated with the consumption of
otherwise wholesome and nutritious food
Provisional Maximum Tolerable Daily Intake (PMTDI)
or Provisional Tolerable Weekly Intake (PTWI)
Health-based Guidance Values (3)
13
Genotoxic carcinogens
Any level can potentially cause adverse effect No
threshold for toxic effect health-based guidance
values CAN NOT be set
Alternative approach for risk assessment Margin of
Exposure (MOE) approach:
A qualitative description for a possible prioritisation
of risks
Base on the benchmark dose derived from dose
response modelling
E.g. acrylamide
Health-based Guidance Values for
Genotoxic Carcinogen?
14
Margin of exposure (MOE) (1)
Benchmark dose (BMD)
Dose corresponding to a specified change in effect
over background, e.g. tumour formation
Modelling based on sufficient experimental data
Mathematical model is selected, based on the data
that are being analysed and the characteristics of the
response
Databases with larger numbers of dose groups and a
greater experimental complexity will be better suited
for more complex models
15
Margin of exposure (MOE) (2)
BMDL (Benchmark dose lower confidence limit)
The lower confidence limit (lower bound 95% confidence limit) of a point on the dose-response curve that characterises adverse effect, to account for uncertainty in the data
BMDL5 or BMDL10 - BMDL give rise to 5% or 10% of effect level
The BMDL can NOT be regarded as a safety reference value
when dietary exposure below the BMDL, it does not mean that there is no health risk
16
BMD & BMDL
Adopted from Anne Constable and Susan Barlow - Application of the Margin of Exposure Approach to Compounds in Food which
are both Genotoxic and Carcinogenic, ILSI
17
Margin of exposure (MOE) (4)
= BMDL10 / Estimated Dietary Exposure
Provide an indication of the level of health concern without actually quantifying the risk
The higher the MOE the lower the health concern
Use for priority setting for risk management actions
Genotoxic carcinogens:
a MOE of 10,000 (based on a BMDL10 from animal study)
low public health concern
18
Example of RA using MOE -
Acrylamide
A food processing contaminant
First reported by the Swedish researchers in 2002
High levels were formed in food during frying or
baking
An industrial chemical that has been used
since the mid 1950s in the production of
polyacrylamide
Also a component of tobacco smoke
19
Formation of acrylamide in food
Form where foods are cooked or processing in high
temperature (usually > 120oC), mainly via Maillard
reactions
* Glucose, fructose, decomposition products of sucrose and other sugars as well as
other suitable intermediates (e.g. aldehydes)
Other formation mechanisms, e.g pyrolysis of the wheat
protein gluten
may be of minor importance
Only trace amounts can be formed by boiling
CH2 NH2 C
NH2
COOH O
asparagine
HC H2C
O
CH NH2 C
acrylamide
Sugar *
20
Toxicity
Toxic to the nervous system of both animals and
human
Reproductive and developmental effects in
animals
Genotoxic
A multi-site carcinogen in rodents
Group 2A agent (IARC)
Probably carcinogenic to humans
21
BMDL for acrylamide
JECFA (2010)
BMDL10
A 10% extra risk of tumours in animals
For Harderian gland tumours in male mice:
0.18 mg/kg bw/day
For mammary tumours in female rats:
0.31 mg/kg bw/day
Epidemiological studies do not provide any consistent evidence that occupational exposure or dietary exposure to acrylamide is associated with cancer in humans
22
RA study on acrylamide in food in
Hong Kong
Study conducted in 2010
Determine the acrylamide levels in local food
Estimate the dietary exposure of the local population
23
Dietary exposure estimation
MOE > 10,000 low concern
Suggest that there is health concern among
the local population because of the relatively
low MOE values
* MOEs were calculated based on the BMDL10 for Harderian
gland tumours in male mice (0.18 mg/kg bw/day)
Dietary exposure (g/kg bw /day) [MOE]
Average High consumer
2010 study 0.13 [1385*] 0.69 [261*] (P97.5)
24
Limitations
Limited sample size
Only focuses on foods which may have higher risk
(in terms of the acrylamide level);
Uncertainties in the exposure estimation
Large variations between brands of the same
product and between batches of the same brand,
thus making direct comparison difficult
25
Advice to Public and Trade
Public
Do not over-heat food but ensure the food is cooked
thoroughly
Maintain a balanced diet i.e. eat more fruits and vegetables
and to moderate the consumption of fried and fatty foods
Trade
To seek ways to reduce the level of acrylamide in food, while
not compromising the safety and nutrition value of the
products
Make reference to the guidelines on reduction in acrylamide
level to be published by CFS
26
27
MOE of various chemicals
10,000 1
310
Acrylamide 65,000
1,3-Dichloro-2-propanol
25,000
Polycyclic aromatic hydrocarbons
19,000
Ethyl carbamate
133,000
Malachite green
28
Conclusion
RA based on Health-based Guidance Values
Deterministic
RA based on MOE
A relative indication of the level of health concern without actually quantifying the risk
29
Conclusion (2)
The MOE approach is both a prioritisation tool and a risk assessment tool, which gives a relative indication of the level of health concern without actually quantifying the risk
In general, small MOEs indicate high concern, and large MOEs low concern
The MOE should always be
accompanied by a narrative to explain the background and the uncertainties in the reference point and exposure estimates
30
Conclusion (3)
Uncertainty
communication between risk assessors and risk managers
communication between risk managers and consumers
Risk Assessors moderate their certainty
Risk Managers hoping for the most certain statements
Consumers perceiving the risk as a function of non scientific
criteria i.e. "outrage factors"
Risk Assessment * Science based
Risk Management * Policy based
Risk Communication * Interactive exchange of information
and opinions concerning risks
Risk Analysis
31
Conclusion (4)
Need for more formalisation in order to help risk managers in dealing with unknowns and uncertainties
Systematic expression of types of uncertainty
Transparency of the level of agreement among experts
Characterization of the level of confidence of experts
Need for improved communication to consumer
Simple language
Clear graphic representation
Assess risk perception
32
Conclusion (5)
Better communication tools on the concept of the MOE approach and resulting levels of concern need to be developed
needs cooperation between risk assessors, risk managers and risk communicators
consumer perceptions about these tools have not yet been addressed adequately
33
Reference
Guidance for Risk Management Options in Light of Different Risk Assessment
Outcomes – Report of the Sixth Session of the Codex Committee on